PACB & Blank Bio Partner to Advance RNA Foundation Models in Oncology

Blank Bio Announces Seed Financing and Strategic Collaboration with PacBio to Advance RNA Foundation Models for Precision Oncology

HiFi Solves Sub-fertility Consortium in Asia Pacific Reports First Major Study Using HiFi Long-Read Sequencing to Investigate Unexplained Subfertility and Recurrent Pregnancy Loss

Pacific Biosciences of California Q1 Earnings Call Highlights

PACB Q1 Earnings Beat, Revenues Miss Estimates, Gross Margin Down

Pacific Biosciences of California, Inc. (PACB) Q1 2026 Earnings Call Transcript

Pacific Biosciences of California (PACB) Reports Q1 Loss, Lags Revenue Estimates

PacBio Announces First Quarter 2026 Financial Results

PacBio Pre-Q1 Analysis: Time to Buy, Hold or Sell the Stock Now?

Critical Review: Autonomix Medical (NASDAQ:AMIX) and Pacific Biosciences of California (NASDAQ:PACB)

Pacific Biosciences of California (PACB) Stock Declines While Market Improves: Some Information for Investors

PacBio & Lucid Genomics Partner to Boost Data Analysis, Stock Up

PacBio and Lucid Genomics Announce Compatibility Collaboration to Advance Tertiary Analysis for Long-Read Sequencing

PacBio Stock Up on New FFPE Workflow Boosting Cancer Sequencing

PacBio to Report First Quarter 2026 Financial Results on May 7, 2026

Why Pacific Biosciences of California (PACB) Outpaced the Stock Market Today

PacBio and Covaris Announce Joint Workflow Enabling HiFi Long-Read Sequencing of FFPE Tumor Samples

Three Best Genomics Stocks for Your Portfolio in 2026

Pacific Biosciences of California (PACB) Laps the Stock Market: Here's Why

Financial Analysis: Pacific Biosciences of California (NASDAQ:PACB) versus DexCom (NASDAQ:DXCM)

Here's Why You Should Add PacBio Stock to Your Portfolio Now

Pacific Biosciences of California (PACB) Registers a Bigger Fall Than the Market: Important Facts to Note

PacBio Wins Basecamp Research Deal for Trillion Gene Atlas Initiative

Pacific Biosciences (PACB) Upgraded to Strong Buy: What Does It Mean for the Stock?

Basecamp Research Selects PacBio HiFi Sequencing to Power Trillion Gene Atlas Initiative

PacBio Announces the Appointment of Chris Gibson to the Board of Directors

Head to Head Survey: Pacific Biosciences of California (NASDAQ:PACB) and NexGel (NASDAQ:NXGL)

PacBio and DNAstack Collaborate on Global HiFi Genome Network Hub

PacBio and DNAstack Launch First Global Federated HiFi Whole Genome Dataset to Accelerate Rare Disease Research

Pacific Biosciences of California (NASDAQ:PACB) Insider Sells $524,232.94 in Stock

Genomics Stocks That Deserve a Place in Your Portfolio in 2026

PacBio to Participate in the TD Cowen 46th Annual Health Care Conference

Pacific Biosciences of California, Inc. (PACB) Q4 2025 Earnings Call Transcript

PacBio Q4 Earnings and Revenues Beat Estimates, Gross Margin Up

Pacific Biosciences of California (PACB) Reports Q4 Loss, Beats Revenue Estimates

PacBio Completes Sale of Short-Read Sequencing Assets

Pacific Biosciences of California, Inc. (NASDAQ:PACB) Receives Consensus Rating of “Hold” from Analysts

Here's Why Pacific Biosciences of California (PACB) Fell More Than Broader Market

PacBio: The Consumables Flywheel Is Turning. The Chart Wants Confirmation

PacBio to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026

Pacific Biosciences of California (PACB) Stock Dips While Market Gains: Key Facts

PacBio Stock Up on HiFi Sequencing Adoption for Major SUDC Research

Pacific Biosciences of California, Inc. (PACB) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

PacBio Announces Plans for Collaboration With n-Lorem Foundation and EspeRare to Advance Precision Therapies for Rare Genetic Diseases

PacBio HiFi Adopted as First-Line Sequencing Approach to Investigate Sudden Unexplained Death in Childhood (SUDC)

PacBio Stock Dips Post Latest Launch to Expand Multiomics Capabilities

PacBio and UC Davis Researchers Introduce CiFi, a New Long-Read 3C Method That Enables Chromosome-Scale Assemblies from a Single SMRT Cell

Here's Why You Should Add PacBio Stock to Your Portfolio

Three Genomics Stocks Worth Tracking This Year

ARK Invest Boosts Gene-Editing Bets While Cutting Consumer Tech Exposure